Literature DB >> 15299376

Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody.

T Bizebard1, R Daniels, R Kahn, B Golinelli-Pimpaneau, J J Skehel, M Knossow.   

Abstract

We report the cDNA sequence determination and the crystal structure of the Fab fragment of a murine IgG1,lambda antibody (HC19), specific for an influenza virus hemagglutinin. The HC19 Fab-fragment structure has been refined; the crystallographic R-factor is 19.5% at 2.3 A resolution. We have compared the conformation of HC19 complementarity determining regions (CDRs) with those of CDR loops of Fab structures available from the Protein Data Bank. These loops were chosen based on the identity of key residues, following the canonical-structure approach; four CDRs have a main-chain conformation very similar to the canonical structure that had been identified. HC19 L1 CDR adopts a conformation clearly distinct from all L1 CDRs that belong to a chain of a different class or origin; this is determined by the nature of a few residues at positions in the sequence different from those of key residues in other light chains. This canonical structure should be representative of most murine lambda-class light chains, as inferred from the very high sequence homologies of these polypeptides.

Entities:  

Year:  1994        PMID: 15299376     DOI: 10.1107/S0907444994001903

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  10 in total

1.  Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.

Authors:  P V Afonin; A V Fokin; I N Tsygannik; I Y Mikhailova; L V Onoprienko; I I Mikhaleva; V T Ivanov; T Y Mareeva; V A Nesmeyanov; N Li; W A Pangborn; W L Duax; V Z Pletnev
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 2.  Structural basis of influenza virus neutralization.

Authors:  Thomas Han; Wayne A Marasco
Journal:  Ann N Y Acad Sci       Date:  2011-01-11       Impact factor: 5.691

3.  Postentry neutralization of adenovirus type 5 by an antihexon antibody.

Authors:  Robin Varghese; Yeshi Mikyas; Phoebe L Stewart; Robert Ralston
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.

Authors:  James A Williams; Long Gui; Nancy Hom; Alexander Mileant; Kelly K Lee
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency.

Authors:  M Chodorge; S Züger; C Stirnimann; C Briand; L Jermutus; M G Grütter; R R Minter
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

6.  Near-native protein loop sampling using nonparametric density estimation accommodating sparcity.

Authors:  Hyun Joo; Archana G Chavan; Ryan Day; Kristin P Lennox; Paul Sukhanov; David B Dahl; Marina Vannucci; Jerry Tsai
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.475

7.  Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding.

Authors:  Henry Memczak; Daniel Lauster; Parimal Kar; Santiago Di Lella; Rudolf Volkmer; Volker Knecht; Andreas Herrmann; Eva Ehrentreich-Förster; Frank F Bier; Walter F M Stöcklein
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

8.  A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines.

Authors:  Shengli Song; Miriam Manook; Jean Kwun; Annette M Jackson; Stuart J Knechtle; Garnett Kelsoe
Journal:  Commun Biol       Date:  2021-11-25

9.  Using molecular principal axes for structural comparison: determining the tertiary changes of a FAB antibody domain induced by antigenic binding.

Authors:  B David Silverman
Journal:  BMC Struct Biol       Date:  2007-11-09

10.  Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization.

Authors:  Dana N Thornlow; Andrew N Macintyre; Thomas H Oguin; Amelia B Karlsson; Erica L Stover; Heather E Lynch; Gregory D Sempowski; Aaron G Schmidt
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.